N/a Injection
Product Images NDC 71053-592

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for N/a (NDC 71053-592). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rafa Laboratories, Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atropine 0.5 mg Unit Label (0.5mg Unit)

Label for Atropine Injection 0.5 mg/0.7 mL auto-injector by Rafa Laboratories, Ltd. It states each auto-injector delivers 0.42 mg Atropine (equivalent to 0.5 mg Atropine Sulfate) for intramuscular use. The label includes storage instructions, lot number and expiration date fields, and administration directions to remove the yellow safety cap and jab the green tip against the outer thigh for 10 seconds. It is intended for nerve agent and insecticide poisoning use and features a barcode.*

FDA Label Image

Atropine 1 mg Unit Label (1mg Unit)

Label of Atropine Injection 1 mg / 0.7 mL auto-injector showing dosage delivering 0.84 mg Atropine for intramuscular use. The label includes usage instructions, storage conditions (do not freeze, store at 25°C with excursions allowed), manufacturer Rafa Laboratories, Jerusalem, and a barcode. It emphasizes use for nerve agent and insecticide poisoning and contains blank fields for lot number and expiration date.*

FDA Label Image

Atropine 01

Chemical structure of Atropine, the active ingredient in Atropine Sulfate Injection USP. The diagram depicts the molecular arrangement including its characteristic bicyclic tropane ring, ester linkage, and phenyl group.*

FDA Label Image

Atropine 02

A flowchart diagram outlining steps to decide the number of Atropine autoinjectors to use for an exposed person. It starts with determining appropriateness of the 2mg Atropine autoinjector based on weight and age, followed by assessing symptoms as mild or severe. Recommendations include using 1 autoinjector for mild symptoms with potential for 2 more if severe symptoms develop, or using 3 autoinjectors immediately if symptoms are severe or the person is unconscious.*

FDA Label Image

Atropine 03

Illustration showing hands removing a protective cap from a vial of Atropine Sulfate Injection USP, 1 mg/0.7 mL. A finger is pressing the cap to uncover the top of the injection vial, demonstrating preparation steps for intramuscular administration.*

FDA Label Image

Atropine 04

An instructional illustration showing a hand holding a syringe labeled with a yellow safety cap at the top and a green tip at the bottom, emphasizing these two components of the injection device.*

FDA Label Image

Atropine 05

An instructional illustration showing a hand removing a yellow safety cap from a vial or syringe. The image labels the yellow cap and depicts the proper grip for removal, indicating a step in medication preparation or administration for Atropine Sulfate Injection.*

FDA Label Image

Atropine 06

Illustrations demonstrating the injection sites for intramuscular administration of Atropine Sulfate Injection USP. The left panel shows self-administration in the thigh area, while the right panel shows a caregiver administering the injection into the arm of a seated patient.*

FDA Label Image

Atropine 07

Illustration showing two injection administration methods for Atropine Sulfate Injection USP. The left panel labeled 'Self Administer' depicts a person injecting into the thigh. The right panel labeled 'Caregiver Aid' shows a caregiver administering the injection into another person's thigh. Both highlight the injection site on the upper thigh area.*

FDA Label Image

Atropine 08

An instructional diagram showing two states of an injection device for Atropine Sulfate Injection USP, 1 mg/0.7 mL. The left side illustrates 'Injection Completed' with the needle visible, while the right side shows 'Injection Not Completed' with the needle not visible. Both devices have green components at the base of the needle.*

FDA Label Image

Atropine 09

An instructional line drawing showing a hand holding a capped vial or ampule horizontally near a corner of a flat surface, demonstrating preparation for use or handling technique.*

FDA Label Image

Atropine 10

Label for Atropine Injection 2 mg / 0.7 mL autoinjector, an intramuscular injection for nerve agent and insecticide poisoning. The label states each autoinjector delivers 1.67 mg atropine (equivalent to 2 mg atropine sulfate). Contains storage instructions, prescription-only status, a quantity of 480 autoinjectors, and is manufactured by Rafa Laboratories, Jerusalem, Israel.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.